Upcoming IPOs
All IPOs

Goldline Pharmaceutical Limited IPO GMP

BSE SMEListed

Pharmaceuticals · Listed on BSE · 12 May 2026 - 14 May 2026

Jagat JoshiJagat Joshi
October 31, 2026
Issue Size
12.00 Cr
Price Band
₹41.00 - ₹43.00
Lot Size
3000 Shares
Min Investment
₹2,58,000
GMP
₹15
Subscription
840.74x
₹6,615.76 Cr
IPO Timeline
IPO OpensDONE
12 May 2026
IPO ClosesDONE
14 May 2026
Basis of AllotmentDONE
15 May 2026
RefundsDONE
18 May 2026
Demat CreditDONE
18 May 2026
ListingDONE
19 May 2026

About Goldline Pharmaceutical Limited IPO

Goldline Pharmaceutical IPO open date is May 12, 2026 and the IPO will close on May 14, 2026. Goldline Pharmaceutical IPO is a Book build Issue. The company to raise around ₹11.61 crores via IPO that comprises fresh issue of ₹11.61 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

Goldline Pharmaceutical IPO price band is ₹41 to ₹43 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Goldline Pharmaceutical IPO to list on BSE SME on May 19, 2026. The allotment of Goldline Pharmaceutical IPO date is May 15, 2026.

The company reported revenue of ₹28.06 crores in 2025 against ₹23.57 crores in 2024. The company reported profit of ₹2.83 crores in 2025 against profit of ₹1.81 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

Advertisement
Back to IPO Details

Day-wise GMP Trend

Date & TimeGMP (₹)Est. Listing PriceEst. Gain (%)Est. Profit / Lot (₹)
20-May-2026 12:00 PM+₹15₹58+34.88%₹45,000
19-May-2026 12:00 PM+₹15₹58+34.88%₹45,000
18-May-2026 12:00 PM+₹18₹61+41.86%₹54,000
16-May-2026 12:00 PM+₹20₹63+46.51%₹60,000
15-May-2026 12:00 PM+₹15₹58+34.88%₹45,000
14-May-2026 12:00 PM+₹15₹58+34.88%₹45,000
13-May-2026 12:00 PM+₹18₹61+41.86%₹54,000
12-May-2026 12:00 PM+₹17₹60+39.53%₹51,000
11-May-2026 12:00 PM+₹16₹59+37.21%₹48,000
09-May-2026 12:00 PM+₹8₹51+18.60%₹24,000
08-May-2026 12:00 PM+₹7₹50+16.28%₹21,000

Goldline Pharmaceutical Limited IPO GMP is ₹15 updated as of 20-May-2026 12:00 PM. The estimated listing gain for Goldline Pharmaceutical Limited is 34.88% with an estimated profit of ₹45,000 per applied lot. Based on the latest GMP, the IPO may list at ₹58.

Goldline Pharmaceutical Limited GMP touched a high of ₹20 on 16 May 2026, while the lowest GMP of ₹7 was recorded on 08 May 2026.

The GMP is available with historical trend, estimated listing price and day-wise grey market movement. The IPO GMP is an unofficial indicator that reflects investor-market sentiment, and demand for an IPO in unofficial market before listing. However, it may fluctuate based on investor demand, market conditions and overall sentiment.

Disclaimer:

The IPO GMP and estimated listing price mentioned on this page are provided for informational and educational purposes only. The grey market is unofficial and unregulated and can change without notice.

We do not buy or sell IPO applications in the grey market. Investors should not subscribe to an IPO based on GMP. Please do your own research and consider the company’s fundamentals, financial information, valuation, and risk factors before investing in an IPO.

Stock market investments are subject to market risks. Please read all offer-related documents carefully before investing.

Advertisement

Goldline Pharmaceutical Limited IPO Lot Size & Estimated Profit

ApplicationLotsSharesEst. Profits (₹)
Individual investors (Retail) (Min)26,000+₹90,000
Individual investors (Retail) (Max)26,000+₹90,000
S-HNI (Min)39,000+₹1,35,000
S-HNI (Max)721,000+₹3,15,000
B-HNI (Min)824,000+₹3,60,000

Grey Market Premium Chart

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by